Life Science Tools Market by Technology, Product, Offerings, Lab Ownership, Lab Size, End-User

Description

List of Tables

The Global Life Science Tools Market is forecasted to grow significantly, with a projected USD 203.93 billion in 2023 at a CAGR of 11.15% and expected to reach a staggering USD 429.19 billion by 2030.

The the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Life Science Tools Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Life Science Tools Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Technology, market is studied across Cell Biology Technology, Genomic Technology, and Proteomics Technology. The Cell Biology Technology commanded largest market share of 42.12% in 2022, followed by Proteomics Technology.

Based on Product, market is studied across Cell Culture Systems & 3D Cell Culture, Cloning & Genome Engineering, Flow Cytometry, Liquid Chromatography, Mass Spectrometry, Microscopy & Electron Microscopy, Next Generation Sequencing, Nuclear Magnetic Resonance, Nucleic Acid Microarray, Nucleic Acid Preparation, PCR & qPCR, Sanger Sequencing, and Transfection Devices & Gene Delivery Technologies. The Cell Culture Systems & 3D Cell Culture is further studied across Media, Reagents, and Sera. The Microscopy & Electron Microscopy commanded largest market share of 10.16% in 2022, followed by Cell Culture Systems & 3D Cell Culture.

Based on Offerings, market is studied across Consumables, Instrument, and Services. The Instrument commanded largest market share of 51.75% in 2022, followed by Services.

Based on Lab Ownership, market is studied across Private and Public. The Private commanded largest market share of 59.12% in 2022, followed by Public.

Based on Lab Size, market is studied across Large, Medium, and Small. The Large commanded largest market share of 46.54% in 2022, followed by Medium.

Based on End-User, market is studied across Academic Research Institutes, Biotechnology Companies, Contract Research Organization/ Contract Manufacturing Organization, Diagnostic Laboratories, and Hospitals. The Contract Research Organization/ Contract Manufacturing Organization commanded largest market share of 24.87% in 2022, followed by Biotechnology Companies.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 38.45% in 2022, followed by Europe, Middle East & Africa.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Life Science Tools Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Life Science Tools Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Life Science Tools Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Life Science Tools Market?

4. What is the competitive strategic window for opportunities in the Global Life Science Tools Market?

5. What are the technology trends and regulatory frameworks in the Global Life Science Tools Market?

6. What is the market share of the leading vendors in the Global Life Science Tools Market?

7. What modes and strategic moves are considered suitable for entering the Global Life Science Tools Market?

Product Code: MRR-2214614772B1

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

4.1. Introduction
4.2. Life Science Tools Market, by Technology, 2022 vs 2030
4.3. Life Science Tools Market, by Product, 2022 vs 2030
4.4. Life Science Tools Market, by Offerings, 2022 vs 2030
4.5. Life Science Tools Market, by Lab Ownership, 2022 vs 2030
4.6. Life Science Tools Market, by Lab Size, 2022 vs 2030
4.7. Life Science Tools Market, by End-User, 2022 vs 2030
4.8. Life Science Tools Market, by Region, 2022 vs 2030

5. Market Insights

5.1. Market Dynamics
- 5.1.1. Drivers
  - 5.1.1.1. Growing need for efficient tools for early diagnosis of chronic diseases
  - 5.1.1.2. Surge in investments toward biotech R&D activities from government and non-government organizations
  - 5.1.1.3. Applications of genomic and proteomic technologies for precision medicine
- 5.1.2. Restraints
  - 5.1.2.1. High cost of life science tools
- 5.1.3. Opportunities
  - 5.1.3.1. Robust technological advancements in life science tools
  - 5.1.3.2. Rapid progress and development of life-science tools in the single-cell isolation and analysis
- 5.1.4. Challenges
  - 5.1.4.1. Quality control issues associated with life science tools
5.2. Market Trends
- 5.2.1. Increase in life science research activities and ongoing advancements in life science tools in the Americas
- 5.2.2. Growing focus on medical research to alleviate the burden of diseases in the APAC region
- 5.2.3. Government investments and initiatives for the advancement of the healthcare sector in the EMEA region
5.3. Cumulative Impact of COVID-19
5.4. Cumulative Impact of Russia-Ukraine Conflict
5.5. Cumulative Impact of High Inflation
5.6. Porter's Five Forces Analysis
- 5.6.1. Threat of New Entrants
- 5.6.2. Threat of Substitutes
- 5.6.3. Bargaining Power of Customers
- 5.6.4. Bargaining Power of Suppliers
- 5.6.5. Industry Rivalry
5.7. Value Chain & Critical Path Analysis
5.8. Regulatory Framework
5.9. Client Customization

6. Life Science Tools Market, by Technology

6.1. Introduction
6.2. Cell Biology Technology
6.3. Genomic Technology
6.4. Proteomics Technology

7. Life Science Tools Market, by Product

7.1. Introduction
7.2. Cell Culture Systems & 3D Cell Culture
- 7.2.1. Media
- 7.2.2. Reagents
- 7.2.3. Sera
7.3. Cloning & Genome Engineering
7.4. Flow Cytometry
7.5. Liquid Chromatography
7.6. Mass Spectrometry
7.7. Microscopy & Electron Microscopy
7.8. Next Generation Sequencing
7.9. Nuclear Magnetic Resonance
7.10. Nucleic Acid Microarray
7.11. Nucleic Acid Preparation
7.12. PCR & qPCR
7.13. Sanger Sequencing
7.14. Transfection Devices & Gene Delivery Technologies

8. Life Science Tools Market, by Offerings

8.1. Introduction
8.2. Consumables
8.3. Instrument
8.4. Services

9. Life Science Tools Market, by Lab Ownership

9.1. Introduction
9.2. Private
9.3. Public

10. Life Science Tools Market, by Lab Size

10.1. Introduction
10.2. Large
10.3. Medium
10.4. Small

11. Life Science Tools Market, by End-User

11.1. Introduction
11.2. Academic Research Institutes
11.3. Biotechnology Companies
11.4. Contract Research Organization/ Contract Manufacturing Organization
11.5. Diagnostic Laboratories
11.6. Hospitals

12. Americas Life Science Tools Market

12.1. Introduction
12.2. Argentina
12.3. Brazil
12.4. Canada
12.5. Mexico
12.6. United States

13. Asia-Pacific Life Science Tools Market

13.1. Introduction
13.2. Australia
13.3. China
13.4. India
13.5. Indonesia
13.6. Japan
13.7. Malaysia
13.8. Philippines
13.9. Singapore
13.10. South Korea
13.11. Taiwan
13.12. Thailand
13.13. Vietnam

14. Europe, Middle East & Africa Life Science Tools Market

14.1. Introduction
14.2. Denmark
14.3. Egypt
14.4. Finland
14.5. France
14.6. Germany
14.7. Israel
14.8. Italy
14.9. Netherlands
14.10. Nigeria
14.11. Norway
14.12. Poland
14.13. Qatar
14.14. Russia
14.15. Saudi Arabia
14.16. South Africa
14.17. Spain
14.18. Sweden
14.19. Switzerland
14.20. Turkey
14.21. United Arab Emirates
14.22. United Kingdom

15. Competitive Landscape

15.1. FPNV Positioning Matrix
15.2. Market Share Analysis, By Key Player
15.3. Competitive Scenario Analysis, By Key Player
- 15.3.1. Merger & Acquisition
  - 15.3.1.1. Berkeley Lights Completed Acquisition of IsoPlexis Forming PhenomeX, the Functional Cell Biology Company
  - 15.3.1.2. Cytek Biosciences to Acquire Flow Cytometry and Imaging Business from DiaSorin
  - 15.3.1.3. Agilent Acquired Life Sciences Company Avida Biomed
- 15.3.2. Agreement, Collaboration, & Partnership
  - 15.3.2.1. Patient Square Capital Partnered with Health Care Veteran John Marotta to Focus on Life Science Tools and Diagnostics Opportunities
  - 15.3.2.2. SCIEX collaborates with Beckman Coulter Life Sciences to bring automation to the Echo MS system
  - 15.3.2.3. Tecan collaborates with Element Biosciences to provide benchtop NGS
  - 15.3.2.4. Agilent to collaborate with Quest Diagnostics to extend access to the Agilent Resolution ctDx FIRST Liquid Biopsy test
  - 15.3.2.5. QIAGEN and Helix Launched Exclusive Partnership to Advance Next-Generation Sequencing Companion Diagnostics in Hereditary Diseases
  - 15.3.2.6. Bruker enters into a strategic partnership with Biognosys
- 15.3.3. New Product Launch & Enhancement
  - 15.3.3.1. Bruker advances NMR magnet portfolio, innovates in industrial solutions
  - 15.3.3.2. Illumina, GenoScreen launched next-generation sequencing innovation to eliminate TB
  - 15.3.3.3. Waters Corporation launched the next generation Alliance iS HPLC System
  - 15.3.3.4. Neogen Launches New Genomic Management Technology
  - 15.3.3.5. Thermo Fisher Launches Next-Generation Sequencing Platform for Labs
- 15.3.4. Investment & Funding
  - 15.3.4.1. BIO-TECHNE completes investment in WILSON WOLF MANUFACTURING
  - 15.3.4.2. UK boosts life science innovation with £277 million funding
  - 15.3.4.3. Novo Holdings invests in a proteomics technology company, Evosep
  - 15.3.4.4. MedGenome Raises USD 50M To Map The Human Genome
- 15.3.5. Award, Recognition, & Expansion
  - 15.3.5.1. GenScript expands footprint in Singapore to provide premium Gene Synthesis service
  - 15.3.5.2. Fluor Selected for Agilent Life Sciences Facility Expansion in Colorado
  - 15.3.5.3. Eurofins expands presence in Indian pharmaceutical market with new state-of-the-art Hyderabad campus
  - 15.3.5.4. Charles River Labs expands CGT capabilities into Cheshire

16. List of Company Mentioned

17. Appendix

17.1. Discussion Guide
17.2. License & Pricing

1. 10x Genomics, Inc.

2. 3M Company

3. Abbott Laboratories

4. Abcam PLC

5. Agilent Technologies, Inc.

6. Avantor, Inc.

7. B. Braun SE

8. Becton, Dickinson, and Company

9. Bio-Rad Laboratories, Inc.

10. Bio-Techne Corporation

11. bioMerieux SA

12. Bruker Corporation

13. Cardinal Health, Inc.

14. Carl Zeiss AG

15. Charles River Laboratories International, Inc.

16. Danaher Corporation

17. Diagnostica Longwood S.L.

18. Eppendorf SE

19. Eurofins Scientific SE

20. F. Hoffmann-La Roche Ltd.

21. Fulgent Genetics, Inc.

22. GE Healthcare Technologies Inc.

23. Genscript Biotech Corporation

24. Hitachi, Ltd.

25. HORIBA, Ltd.

26. ICON PLC

27. Illumina, Inc.

28. IQVIA Holdings Inc.

29. Laboratory Corporation of America Holdings

30. Lonza Group Ltd.

31. Luminex Corporation

32. Merck KGaA

33. Mettler-Toledo International Inc.

34. New England Biolabs, Inc.

35. Oxford Instruments PLC

36. PerkinElmer, Inc.

37. Promega Corporation

38. QIAGEN N.V.

39. Quest Diagnostics Incorporated

40. Repligen Corporation

41. Sartorius AG

42. SGS SA

43. Shimadzu Corporation

44. Takara Bio Inc.

45. Tecan Trading AG

46. Thermo Fisher Scientific Inc.

47. Waters Corporation

48. WuXi AppTec Co., Ltd